Get the Stockscreener App
2.28
6.05%
0.13
After Hours:
2.22
-0.06
-2.63%
Ac Immune Sa stock is traded at $2.28, with a volume of 244.22K.
It is up +6.05% in the last 24 hours and down -6.94% over the past month.
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
See More
Previous Close:
$2.15
Open:
$2.15
24h Volume:
244.22K
Relative Volume:
1.79
Market Cap:
$228.94M
Revenue:
-
Net Income/Loss:
$-60.14M
P/E Ratio:
-3.2135
EPS:
-0.7095
Net Cash Flow:
$-68.17M
1W Performance:
+11.76%
1M Performance:
-6.94%
6M Performance:
-8.80%
1Y Performance:
-26.69%
1-Day Range:
$2.14
$2.35
1-Week Range:
$2.04
$2.35
52-Week Range:
$1.4299
$3.98
Ac Immune Sa Stock (ACIU) Company Profile
Compare ACIU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
2.28 | 216.29M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-31-24 | Initiated | BTIG Research | Buy |
| Feb-01-19 | Downgrade | UBS | Buy → Neutral |
| Jan-04-19 | Initiated | UBS | Buy |
| Apr-05-18 | Initiated | H.C. Wainwright | Buy |
| Mar-23-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Oct-18-16 | Initiated | Credit Suisse | Outperform |
| Oct-18-16 | Initiated | Jefferies | Buy |
| Oct-18-16 | Initiated | Leerink Partners | Outperform |
View All
Ac Immune Sa Stock (ACIU) Latest News
Understanding AC Immune SA’s price movementTrade Analysis Report & Daily Volume Surge Signals - Newser
Tick level data insight on AC Immune SA volatilityJuly 2025 Closing Moves & Free Community Supported Trade Ideas - Newser
How moving averages guide AC Immune SA tradingGap Up & Daily Growth Stock Tips - Newser
Full technical analysis of AC Immune SA stockWall Street Watch & Weekly Top Gainers Trade List - Newser
What is AC Immune SA’s book value per shareJuly 2025 Intraday Action & Community Shared Stock Ideas - خودرو بانک
Can AC Immune SA disrupt its industryEarnings Risk Summary & Detailed Earnings Play Strategies - خودرو بانک
Volatility clustering patterns for AC Immune SAWeekly Stock Recap & High Return Stock Watch Alerts - Newser
Will AC Immune SA continue its uptrendMarket Trend Report & Capital Protection Trade Alerts - Newser
AC Immune Cuts Workforce As Key Parkinson’s Readout Nears - insights.citeline.com
How to forecast AC Immune SA trends using time seriesJuly 2025 Update & AI Powered Market Entry Strategies - Newser
Forecasting AC Immune SA price range with options dataSwing Trade & Weekly Watchlist for Hot Stocks - Newser
Volume Profile Shows Strong Base for AC Immune SAMarket Volume Summary & AI Forecast for Swing Trade Picks - 더경남뉴스
Risk adjusted return profile for AC Immune SA analyzedRate Hike & Weekly Watchlist of Top Performers - Newser
What does recent volatility data suggest for AC Immune SATrend Reversal & Reliable Entry Point Alerts - Newser
Analyzing drawdowns of AC Immune SA with statistical toolsJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - Newser
What’s the recovery path for long term holders of AC Immune SATrade Risk Report & Long-Term Safe Investment Plans - Newser
AC Immune shares fall 5.71% intraday after announcing a 30% workforce reduction. - AInvest
Will AC Immune SA stock go up in YEARJuly 2025 PreEarnings & Short-Term High Return Strategies - خودرو بانک
Should I trade or invest in AC Immune SAJuly 2025 Weekly Recap & Daily Stock Trend Reports - خودرو بانک
AC Immune SA Announces Strategic Focus and Workforce Reduction - TipRanks
AC Immune SA stock trendline breakdownQuarterly Earnings Summary & Stepwise Trade Execution Plans - Newser
AC Immune to Cut 30% of Workforce - MarketScreener
Visual analytics tools that track AC Immune SA performanceWeekly Volume Report & Step-by-Step Swing Trade Plans - Newser
AC Immune SA Announces Strategic Pipeline Focus and Workforce Reduction to Extend Cash Runway - Quiver Quantitative
Biotech AC Immune Extends Cash Runway to 2027 Through Major Restructuring of Neurodegenerative Pipeline - Stock Titan
Guidance Update: What is AC Immune SA’s book value per shareJuly 2025 Sentiment & Fast Exit and Entry Trade Guides - خودرو بانک
Identifying reversal signals in AC Immune SAMarket Risk Analysis & Consistent Return Strategy Ideas - Newser
Will AC Immune SA bounce back from current support2025 Stock Rankings & Low Drawdown Momentum Ideas - Newser
Market reaction to AC Immune SA’s recent newsBear Alert & Community Consensus Picks - Newser
Is AC Immune SA a cyclical or defensive stockQuarterly Profit Review & Risk Adjusted Buy/Sell Alerts - khodrobank.com
Portfolio Update: Can AC Immune SA expand its profit marginsShare Buyback & Accurate Buy Signal Alerts - خودرو بانک
Published on: 2025-09-03 00:47:27 - Newser
Order flow analysis tools used on AC Immune SA2025 Price Action Summary & Weekly Chart Analysis and Trade Guides - Newser
Risk Recap: Can AC Immune SA disrupt its industryMarket Performance Report & Safe Capital Growth Plans - خودرو بانک
What drives AC Immune SA’s stock priceTrade Entry Report & Technical Entry and Exit Alerts - خودرو بانک
Can you recover from losses in AC Immune SAMarket Performance Report & Verified Stock Trade Ideas - Newser
Price action breakdown for AC Immune SAWeekly Trend Recap & Verified Stock Trade Ideas - Newser
Ac Immune Sa Stock (ACIU) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):